# Dyne Therapeutics, Inc. (DYN) - Q4 2025 earnings

Reported March 2, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.76 | $-0.74 |

Earnings filing reader: [8-K 0001193125-26-084207](https://www.opencapital.sh/filings/0001193125-26-084207)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-084207.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1818794/000119312526084207/0001193125-26-084207-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1818794/000119312526084178/0001193125-26-084178-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/dyn/earnings/q4-2025